Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies9,081–9,100 of 20,710
All studies
LINC00173 regulates polycystic ovarian syndrome progression by promoting apoptosis and repressing proliferation in ovarian granulosa cells via the microRNA-124-3p (miR-124-3p)/jagged canonical Notch ligand 1 (JAG1) pathway.
Global Transcriptional Profiling of Granulosa Cells from Polycystic Ovary Syndrome Patients: Comparative Analyses of Patients with or without History of Ovarian Hyperstimulation Syndrome Reveals Distinct Biomarkers and Pathways
Effects of clinical and metabolic variables and hormones on the expression of immune protein biomarkers in the endometrium of women with polycystic ovary syndrome and normal-cycling controls
Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis.
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome
The effects of cognitive behavioral therapy in women with polycystic ovary syndrome: A meta-analysis
Long non-coding RNA HLA-F antisense RNA 1 inhibits the maturation of microRNA-613 in polycystic ovary syndrome to promote ovarian granulosa cell proliferation and inhibit cell apoptosis
The effect of mildly stimulated cycle versus artificial cycle on pregnancy outcomes in overweight/obese women with PCOS prior to frozen embryo transfer: a retrospective cohort study
The PNA mouse may be the best animal model of polycystic ovary syndrome
Unusual suspects: Glial cells in fertility regulation and their suspected role in polycystic ovary syndrome
Polycystic Ovary Syndrome and Gut Microbiota: Phenotype Matters
Polycystic ovary syndrome and leukocyte telomere length: cross-sectional and longitudinal changes
Association of antimüllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer.
Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology
The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS
Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial
An integrated multidisciplinary model of care for addressing comorbidities beyond reproductive health among women with polycystic ovary syndrome in India
Ethnic diversity and burden of polycystic ovary syndrome among US adolescent females
Role of Single Nucleotide Variants in the YAP1 Gene in Adolescents with Polycystic Ovary Syndrome
Distress response in granulosa cells of women affected by PCOS with or without insulin resistance